貝因美(002570.SZ)擬1.09億元出售北海寧神49%股權
格隆匯12月17日丨貝因美(002570.SZ)公佈,為進行適當戰略收縮,聚焦主業,實現資產回報,公司全資子公司北海貝因美營養食品有限公司(以下簡稱“北海貝因美”)擬出售其參股子公司北海寧神沉香產業發展有限公司(以下簡稱“北海寧神”)49%的股權,本次轉讓價格不得低於北海貝因美初始出資額1.09億元,且不低於未來股權評估值,其中股權評估值待土地完成出資手續、符合交易條件後由具有證券從業資質的評估機構作出。交易對手方尚不確定,目前尚未簽署任何交易協議。對公司的經營情況及財務狀況的影響尚不確定。
北海貝因美擬用於向北海寧神出資的土地尚未完成過户。
北海寧神註冊資本為2.23億元,其中,廣西寧神生物科技有限公司以貨幣出資1.14億元,佔註冊資本的51%;北海貝因美以機器設備、土地使用權等實物合計出資1.09億元,佔註冊資本的49%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.